Detalhe da pesquisa
1.
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).
Jpn J Clin Oncol
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594880
2.
Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.
Cancer Immunol Immunother
; 72(8): 2829-2840, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188764
3.
Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study).
Future Oncol
; 19(22): 1515-1521, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37577772
4.
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant.
Eur J Clin Pharmacol
; 78(4): 613-621, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35039908
5.
Uncommon EGFR mutations conducted with osimertinib in patients with NSCLC: a study protocol of phase 2 study (UNICORN/TCOG1901).
Future Oncol
; 18(5): 523-531, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35034503
6.
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
N Engl J Med
; 379(24): 2342-2350, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280658
7.
Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable stage III non-small-cell lung cancer.
Future Oncol
; 17(10): 1165-1184, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33583206
8.
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med
; 377(20): 1919-1929, 2017 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28885881
9.
Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer.
Cancer Immunol Immunother
; 69(7): 1229-1236, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32152703
10.
Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody.
Cancer Immunol Immunother
; 69(1): 15-22, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31745589
11.
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Lancet Oncol
; 20(12): 1670-1680, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601496
12.
Multi-parameter distributed fiber sensing with higher-order optical and acoustic modes.
Opt Lett
; 44(5): 1096-1099, 2019 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30821779
13.
Phase II study of bevacizumab, cisplatin, and pemetrexed in advanced non-squamous non-small cell lung cancer (NS-NSCLC) with EGFR wild-type.
J Exp Ther Oncol
; 13(2): 131-138, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31881129
14.
Nedaplatin and irinotecan with concurrent thoracic radiotherapy followed by docetaxel consolidation in patients with locally advanced non-small cell lung cancer.
J Exp Ther Oncol
; 12(1): 17-23, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28472560
15.
Acute eosinophilic pneumonia after changing dosing schedule of nivolumab.
Jpn J Clin Oncol
; 51(12): 1766-1767, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34345910
16.
Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma.
Jpn J Clin Oncol
; 46(11): 1015-1021, 2016 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27566971
17.
Clonality analysis performed using human androgen receptor assay in a rare case of undifferentiated thymic carcinoma coexisting with type AB thymoma.
Pathol Int
; 66(7): 398-403, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27321590
18.
Clinicopathological features and EGFR gene mutation status in elderly patients with resected non-small-cell lung cancer.
BMC Cancer
; 14: 610, 2014 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25152277
19.
Nivolumab-induced autoimmune encephalitis in an anti-neuronal autoantibody-positive patient.
Jpn J Clin Oncol
; 49(8): 793-794, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31187869
20.
First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations: The UNICORN Phase 2 Nonrandomized Clinical Trial.
JAMA Oncol
; 10(1): 43-51, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991747